DUB is almost back to their IPO price..., page-8

DUB has made it very clear that they have funding in place to borrow against to managing the time-delay in receiving R&D grants.  

Can anyway shed any light on the lending practices and the businesses that operate in this space, relating to ‘pending’ or ‘future’ R&D payments for companies.

Future meaning ‘already approved R&D grants and payment delays and ‘pending’ approval, which is where DUB is now with their FY17 grant application.

DUB's 1 May Qtrly Activity Statements clearly explains that this is what they do “ Subsequent to the close of the March quarter, the Company finalised it’s FY16 R&D claim, and received an additional cash inflow of $460k after paying off the loan of 1.1m tied to this payment”.

They have only applied for FY17 R&D grant, according to DUB’s statement, “The Company ‘anticipates’ that it’s FY17R&D claim will be in excess of $1.5m (and has a track record of successfully demonstrating the validity of it’s R&D claims with the ATO..)

So given DUB need funding to stay operational, and this is clearly provided against the future ‘pending’ receipts’ relating to R&D grant my question is

1. What is the name of business that lends this money to DUB, against their pending R&D grant, and
2. what impact, if any, impact is their on the ability to borrow this money, given DUB’s SP having dropped to circa .20c.